Matches in SemOpenAlex for { <https://semopenalex.org/work/W1952921626> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W1952921626 endingPage "10" @default.
- W1952921626 startingPage "6705" @default.
- W1952921626 abstract "We examined whether Circulating Tumor Cells (CTCs) can be used to predict survival in patients with bone-metastatic castration-resistant-prostate cancer (mCRPC) treated with docetaxel chemotherapy.All patients with mCRPC who had experienced treatment failure with androgen deprivation therapy and had received docetaxel chemotherapy were eligible for study inclusion. CTCs in whole blood were enumerated with the CellSearch System.The median CTC count at baseline before starting trial treatment was 7 (range=0-227) CTCs per 7.5 ml blood. Out of the 57 patients, 24 (42.1%) had a CTC count of less than 5, while 27 patients (47.4%) had a CTC count of 5-50 and six patients (10.5%) had a CTC count of more than 50. A threshold of 5 or more CTCs per 7.5 ml blood was used to assess the ability to predict survival. The patient charts were examined to determine the median overall survival time, which ranged from 6 to 37 months (mean=12.8±8.1 months, median=15.3 months). Thirty-three patients (57.9%) had 5 or more CTCs before docetaxel chemotherapy, with a median overall survival of 10.5 months compared to 25.0 months for 24 patients (42.1%) with fewer than 5 CTCs (p<0.001). CTC and alkaline phosphatase (ALP) were independent predictors of overall survival time (p=0.004, and p=0.023, respectively). In addition, poorer overall survival was predicted by a CTC count of 5 or more after three courses of docetaxel chemotherapy.The CTC count may be an independent predictor of overall survival in patients with mCRPC treated with docetaxel chemotherapy. The numbers of CTCs detected was important in assessing response to chemotherapy and predict disease outcome." @default.
- W1952921626 created "2016-06-24" @default.
- W1952921626 creator A5015753233 @default.
- W1952921626 creator A5021574779 @default.
- W1952921626 creator A5048648363 @default.
- W1952921626 creator A5055823237 @default.
- W1952921626 creator A5064341902 @default.
- W1952921626 date "2014-11-01" @default.
- W1952921626 modified "2023-10-12" @default.
- W1952921626 title "Circulating tumor cells as a biomarker predictive of sensitivity to docetaxel chemotherapy in patients with castration-resistant prostate cancer." @default.
- W1952921626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25368278" @default.
- W1952921626 hasPublicationYear "2014" @default.
- W1952921626 type Work @default.
- W1952921626 sameAs 1952921626 @default.
- W1952921626 citedByCount "23" @default.
- W1952921626 countsByYear W19529216262015 @default.
- W1952921626 countsByYear W19529216262016 @default.
- W1952921626 countsByYear W19529216262017 @default.
- W1952921626 countsByYear W19529216262018 @default.
- W1952921626 countsByYear W19529216262019 @default.
- W1952921626 countsByYear W19529216262020 @default.
- W1952921626 countsByYear W19529216262022 @default.
- W1952921626 countsByYear W19529216262023 @default.
- W1952921626 crossrefType "journal-article" @default.
- W1952921626 hasAuthorship W1952921626A5015753233 @default.
- W1952921626 hasAuthorship W1952921626A5021574779 @default.
- W1952921626 hasAuthorship W1952921626A5048648363 @default.
- W1952921626 hasAuthorship W1952921626A5055823237 @default.
- W1952921626 hasAuthorship W1952921626A5064341902 @default.
- W1952921626 hasConcept C121608353 @default.
- W1952921626 hasConcept C126322002 @default.
- W1952921626 hasConcept C126894567 @default.
- W1952921626 hasConcept C143998085 @default.
- W1952921626 hasConcept C185592680 @default.
- W1952921626 hasConcept C2776694085 @default.
- W1952921626 hasConcept C2779013556 @default.
- W1952921626 hasConcept C2780192828 @default.
- W1952921626 hasConcept C2781190966 @default.
- W1952921626 hasConcept C2781197716 @default.
- W1952921626 hasConcept C55493867 @default.
- W1952921626 hasConcept C61238886 @default.
- W1952921626 hasConcept C71924100 @default.
- W1952921626 hasConceptScore W1952921626C121608353 @default.
- W1952921626 hasConceptScore W1952921626C126322002 @default.
- W1952921626 hasConceptScore W1952921626C126894567 @default.
- W1952921626 hasConceptScore W1952921626C143998085 @default.
- W1952921626 hasConceptScore W1952921626C185592680 @default.
- W1952921626 hasConceptScore W1952921626C2776694085 @default.
- W1952921626 hasConceptScore W1952921626C2779013556 @default.
- W1952921626 hasConceptScore W1952921626C2780192828 @default.
- W1952921626 hasConceptScore W1952921626C2781190966 @default.
- W1952921626 hasConceptScore W1952921626C2781197716 @default.
- W1952921626 hasConceptScore W1952921626C55493867 @default.
- W1952921626 hasConceptScore W1952921626C61238886 @default.
- W1952921626 hasConceptScore W1952921626C71924100 @default.
- W1952921626 hasIssue "11" @default.
- W1952921626 hasLocation W19529216261 @default.
- W1952921626 hasOpenAccess W1952921626 @default.
- W1952921626 hasPrimaryLocation W19529216261 @default.
- W1952921626 hasRelatedWork W2299690226 @default.
- W1952921626 hasRelatedWork W2506736007 @default.
- W1952921626 hasRelatedWork W2599010040 @default.
- W1952921626 hasRelatedWork W2750239114 @default.
- W1952921626 hasRelatedWork W3016249874 @default.
- W1952921626 hasRelatedWork W3023106870 @default.
- W1952921626 hasRelatedWork W3111556708 @default.
- W1952921626 hasRelatedWork W3153927195 @default.
- W1952921626 hasRelatedWork W3204029969 @default.
- W1952921626 hasRelatedWork W2468073370 @default.
- W1952921626 hasVolume "34" @default.
- W1952921626 isParatext "false" @default.
- W1952921626 isRetracted "false" @default.
- W1952921626 magId "1952921626" @default.
- W1952921626 workType "article" @default.